Literature DB >> 28847205

Moderate, but not vigorous, intensity exercise training reduces C-reactive protein.

Michael V Fedewa1,2, Elizabeth D Hathaway2,3, Simon Higgins2, Ronald L Forehand4, Michael D Schmidt2, Ellen M Evans2.   

Abstract

BACKGROUND: Sprint interval cycle training is a contemporary popular mode of training but its relative efficacy, under conditions of matched energy expenditure, to reduce risk factors for cardiometabolic disease is incompletely characterised, especially in young women. The purpose of this investigation was to determine the relative efficacy of six weeks of moderate-intensity cycling (MOD-C) and vigorous sprint-interval cycling (VIG-SIC) on lipid profile, insulin (INS) and insulin resistance using the homeostatic model assessment (HOMA-IR) and C-reactive protein (CRP) in inactive, overweight/obese (OW/OB) young women.
METHODS: Participants (BMI ≥25 kg/m2, waist circumference ≥88 cm) were randomly assigned to MOD-C (20-30 min at 60-70% of heart rate reserve(HRR)) or VIG-SIC (5-7 repeated bouts 30-second maximal effort sprints, followed by four minutes of active recovery) supervised training three days/week for six weeks, with each group matched on energy expenditure. Adiposity (%Fat) was measured using dual x-ray absorptiometry.
RESULTS: Forty-four participants (20.4 ± 1.6 years, 65.9% Caucasian, 29.8 ± 4.1 kg/m2) were included in the analysis. The improvement in CRP observed in the MOD-C group was larger than the VIG-C group (p = .034). Overall, high-density lipoprotein (HDL-C) and low-density lipoprotein (LDL-C) levels improved following training (p < .05); however, total cholesterol, triglyceride, INS and HOMA-IR did not improve (p > .05).
CONCLUSION: These results indicate MOD-C training may be more effective in reducing CRP than VIG-SIC.

Entities:  

Keywords:  C-reactive protein; aerobic exercise; obese; overweight

Mesh:

Substances:

Year:  2017        PMID: 28847205     DOI: 10.1080/00015385.2017.1364832

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  6 in total

1.  The Effect of Low-Volume High-Intensity Interval Training on Body Composition and Cardiorespiratory Fitness: A Systematic Review and Meta-Analysis.

Authors:  Rachelle N Sultana; Angelo Sabag; Shelley E Keating; Nathan A Johnson
Journal:  Sports Med       Date:  2019-11       Impact factor: 11.136

2.  Does a Course of Aerobic Training Affect the Inflammatory Status and Cardiometabolic Risk Factors of Hookah-smoker Women? Results of a Cross-sectional Study.

Authors:  Abbas Saremi; Mohammad Parastesh; Manijeh Tavangar
Journal:  Addict Health       Date:  2022-01

3.  Effect of aerobic and resistance training on inflammatory markers in heart failure patients: systematic review and meta-analysis.

Authors:  M J Pearson; S F Mungovan; N A Smart
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

4.  Effect of Volume in Resistance Training on Inhibitory Control in Young Adults: A Randomized and Crossover Investigation.

Authors:  Leonardo de Sousa Fortes; Manoel da Cunha Costa; Raphael José Perrier-Melo; Jorge Luís Brito-Gomes; José Roberto Andrade Nascimento-Júnior; Dalton Roberto Alves Araújo de Lima-Júnior; Edilson Serpeloni Cyrino
Journal:  Front Psychol       Date:  2018-10-29

5.  Intradialytic Cardiovascular Exercise Training Alters Redox Status, Reduces Inflammation and Improves Physical Performance in Patients with Chronic Kidney Disease.

Authors:  Apostolos Sovatzidis; Athanasios Chatzinikolaou; Ioannis G Fatouros; Stylianos Panagoutsos; Dimitrios Draganidis; Eirini Nikolaidou; Alexandra Avloniti; Yiannis Michailidis; Ioannis Mantzouridis; Alexios Batrakoulis; Ploumis Pasadakis; Vassilis Vargemezis
Journal:  Antioxidants (Basel)       Date:  2020-09-15

6.  Effect of Exercise Training on Body Composition and Inflammatory Cytokine Levels in Overweight and Obese Individuals: A Systematic Review and Network Meta-Analysis.

Authors:  Shengya Wang; Huayi Zhou; Changtao Zhao; Hui He
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.